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PHA310 – Clinical Pharmacokinetics 
DURATION 
 
Reading Time: 10 minutes 
Writing Time: 180 minutes 
 
INSTRUCTIONS TO CANDIDATES 
 
The examination has 2 Sections (A and B): 
Section A contains Forty (40) Multiple Choice Questions.  Answer all questions on the College supplied 
Multiple Choice Answer Sheet.  Total marks allocated: Forty (40).  Suggested time allocation: One hour 
(60 minutes). 
 
Section B contains Five (5) Calculation Questions.  Answer all questions in the 20-page Booklet 
provided.  Show all relevant steps in your calculations and include all relevant units in your answers.  
Total marks allocated: One hundred (100). Suggested time allocation: Two hours (120) minutes. 
 
Total marks for this exam paper: 140 
 
EXAM CONDITIONS 
You may begin writing from the commencement of the examination session.  The reading time indicated above is 
provided as a guide only. 
This is a CLOSED BOOK examination 
Any non-programmable calculator is permitted 
No handwritten notes are permitted 
No dictionaries are permitted 
 
ADDITIONAL AUTHORISED MATERIALS EXAMINATION MATERIALS TO BE SUPPLIED 
 
No additional printed material is permitted 
 
 
1 x 20 Page Book 
1 x Scrap Paper 
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Multiple Choice Questions 
Total No of Marks for this section: 40 
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Total Marks for this section: 100 
Answer ALL Five (5) questions 
This section should be answered in the 20-page Answer Booklet provided. 
Marks for each question are indicated. 
Show all relevant steps in your calculations and include all relevant units in your answers. 
Suggested Time allocation for Section B:  120 min 
 
Question 1 (28 marks; Suggested time allocation 32 min)  
After a single IV bolus dose of 1000mg of an antiarrhythmic drug, the following concentrations were 
obtained: 
Time (hr) Plasma Drug 
Concentration 
(mg/L) 
Time (hr) Plasma Drug 
Concentration 
(mg/L) 
0.2 120 4 18 
0.5 84 6 15 
1 53 8 12.5 
2 29 12 8.8 
 
a Using the method of residuals, calculate the following parameters: t½, t½, k12, k21, k10, Vc, 
Vd, Vdss, AUC and CLT. 
 (25 marks) 
b What will be the amount of the drug remaining in the body after 15 hours?  
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Question 2 (10 marks; Suggested time allocation 12 min)  
Mrs DB, a 47-year old, 62 kg female is admitted to the hospital due to acute pneumonia. She is receiving 
100 mg gentamicin as repeated IV infusions (for half an hour) every 8 hours. Her serum creatinine is 
found to be 2.5 mg/dL. Assuming the clearance of the antibiotic is 7.2L/hr with an elimination half-life 
(t½) of 3 hours: 
a Estimate the creatinine clearance in this patient. 
 (2 marks) 
b Calculate the plasma concentration of the antibiotic in Mrs DB after the first IV infusion. 
 (2 marks) 
c Calculate Cmax, Cmin and Caverage of this antibiotic in Mrs DB at steady-state. 
 
 (6 marks) 
Question 3 (16 marks; Suggested time allocation 20 min)  
A patient received an antibiotic as a single 250mg IV bolus dose, and a single 500mg in the form of an 
oral capsule on two separate occasions, and the following plasma concentrations were obtained: 
Time 
(hr) 
IV bolus (250mg) Capsule (500mg) 
Drug Concentrations in Plasma, Cp (mg/L) 
1 6.3 3.1 
2 5.0 4.7 
3 4.0 5.2 
4 3.2 5.3 
6 2.0 4.5 
8 1.3 3.4 
12 0.5 1.7 
The half-life (t½) of this antibiotic is 3 hr and the absorption process is complete after 12 hr of oral 
administration.  
Calculate the absolute bioavailability of the IV bolus injection and the oral capsule of this antibiotic. 
 (16 marks) 
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Question 4 (18 marks; Suggested time allocation 24 min)  
a A 32-year-old 70kg male with generalised tonic-clonic seizures is being treated with phenytoin.  
Assuming Michaelis-Menten parameters of Vmax = 450mg/d and Km = 5mg/L, calculate a dose of 
phenytoin that will achieve a steady-state concentration (Css) of 15mg/L. 
 (2 marks) 
b Mr AT, a 50-year-old 75kg male, was prescribed a daily oral dose of 250mg phenytoin to control 
his simple partial seizures.  After 1 month of therapy, his serum steady-state concentration was 
measured at 5mg/L.  Since this was insufficient to control his seizures, his daily oral phenytoin 
dose was increased to 240mg b.d. (i.e. twice daily).  One month after starting this new dosage 
regimen, Mr AT developed lateral-gaze nystagmus and his serum phenytoin concentration was 
found to be 25mg/L.  Assuming that the volume of distribution of phenytoin is 0.7L/kg and the 
absolute bioavailability of oral phenytoin is 100%: 
i. Use the direct linear plot (Mullen Method – with proper labels) to determine the Vmax 
and Km for phenytoin in Mr AT. 
 (10 marks) 
ii. Recommend a dosage regimen to maintain steady-state plasma phenytoin 
concentration around 15mg/L (therapeutic range 10-20mg/L). 
 (2 marks) 
iii. What will be the half-life (t½) of phenytoin at steady-state if a dose of 200mg every 12 
hours was given to Mr AT? 
 (4 marks) 
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Question 5 (28 marks; Suggested time allocation 32 min)  
Mr ST (60 kg) received a single oral dose of 25 mg of an antibiotic that is completely absorbed after oral 
administration (F = 1). The following plasma concentration time data were obtained using a sensitive 
analytical method: 
Time (hr) Plasma Drug 
Concentration (ng/mL) 
Time (hr) Plasma Drug 
Concentration (ng/mL) 
0 0.00 4.0 246.1 
0.2 88.5 6.0 161.0 
0.5 184.9 8.0 102.2 
1.0 276.9 10.0 64.5 
2.0 321.6 12.0 40.66 
3.0 292.8 14.0 25.61 
a Plot the plasma concentration-time curve (with proper labels) and determine the elimination 
rate constant (k), and half-life (t½) of this bronchodilator in Mr ST. 
 (10 marks) 
b Use the method of residuals to calculate the absorption rate constant (ka). 
 (10 marks) 
c What is the equation that describes the plasma concentration time profile of this drug in Mr ST 
after oral administration? 
 (4 marks) 
d Calculate the tmax and Cmax. 
 (4 marks) 
 
End of Section B 
 
 
End of Exam Paper 
